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Abstract
Background: The prehospital identification of stroke patients with large-vessel occlusion (LVO), that should be
immediately transported to a thrombectomy capable centre is an unsolved problem. Our aim was to determine
whether implementation of a state-wide standard operating procedure (SOP) using the Los Angeles Motor Scale
(LAMS) is feasible and enables correct triage of stroke patients to hospitals offering (comprehensive stroke centres,
CSCs) or not offering (primary stroke centres, PSCs) thrombectomy.
Methods: Prospective study involving all patients with suspected acute stroke treated in a 4-month period in a
state-wide network of all stroke-treating hospitals (eight PSCs and two CSCs). Primary endpoint was accuracy of the
triage SOP in correctly transferring patients to CSCs or PSCs. Additional endpoints included the number of secondary
transfers, the accuracy of the LAMS for detection of LVO, apart from stroke management metrics.
Results: In 1123 patients, use of a triage SOP based on the LAMS allowed triage decisions according to LVO status
with a sensitivity of 69.2% (95% confidence interval (95%-CI): 59.0–79.5%) and a specificity of 84.9% (95%-CI: 82.6–
87.3%). This was more favourable than the conventional approach of transferring every patient to the nearest stroke-
treating hospital, as determined by geocoding for each patient (sensitivity, 17.9% (95%-CI: 9.4–26.5%); specificity, 100%
(95%-CI: 100–100%)). Secondary transfers were required for 14 of the 78 (17.9%) LVO patients. Regarding the score
itself, LAMS detected LVO with a sensitivity of 67.5% (95%-CI: 57.1–78.0%) and a specificity of 83.5% (95%-CI: 81.0–
86.0%).
Conclusions: State-wide implementation of a triage SOP requesting use of the LAMS tool is feasible and improves
triage decision-making in acute stroke regarding the most appropriate target hospital.
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Background
Stroke is a frequent cause of disability and death [1] with
important medical and economic implications. When
stroke is caused by large-vessel occlusion (LVO), trials
provide compelling evidence that mechanical thrombec-
tomy (MT) rather than medical treatment alone is most
effective. Even so, although an estimated 10 to 25% of
patients with stroke have LVO [2, 3], only a small mi-
nority (fewer than 7%) are treated with MT [2, 4, 5]. A
main reason for this difference is that MT is not avail-
able at the many primary stroke centres (PSCs) but is of-
fered only by a few specialized stroke centres
(comprehensive stroke centres, CSCs).
Currently, stroke-management guidelines recommend
the transport of all patients to the nearest stroke-ready
hospital [6], which in most cases is a PSC not offering
MT. Therefore, patients with LVO may secondarily be
transferred to a CSC for thrombectomy. Importantly,
compared with direct referral to a CSC, such interhospi-
tal transfers cause pronounced treatment delays ranging
from 96min to 111 min for patients with LVO [7–10].
Consistent with the “time is brain” concept [8], these de-
lays significantly worsen clinical outcomes [9, 11]. On
the other hand, not all patients with stroke should be
transferred to CSCs because, apart from overwhelming
already strained accident and emergency departments,
bypassing PSCs could delay the administration of intra-
venous thrombolysis for most patients.
LVO is mostly associated with more severe stroke
symptoms. Therefore, researchers have proposed the use
in the field of stroke severity scales aimed at prehospi-
tally detecting LVO; patients with LVO could then profit
from direct transfer to a CSC. Recently, many LVO
scales, such as the Los Angeles Motor Scale (LAMS)
[12], the Rapid Arterial Occlusion Evaluation Scale
(RACE) [13–15] or the A2L2 test (A, arm; L, leg) [16]
have been proposed and studied by EMS in regard to
their accuracy of detecting LVO.
Because the LAMS, apart from belonging to the most
predictive of those scales [17, 18], requires assessment of
only three motor symptoms (facial paresis, arm strength,
and grip strength) [12, 19], it appears most suitable for im-
plementation in prehospital emergency care protocols.
However, information on the effects of implementation
of the LAMS for real-life triage of stroke patients is still
missing. The aim of this study is to explore the effects of a
state-wide triage standard operating procedure (SOP)
requesting performance of the LAMS for triage decision-
making in regard to the most appropriate target hospital.
Methods
Patients and study design
This prospective multicentre study, coordinated by the
University of the Saarland, Germany, was opened on
March 1, 2018, and terminated on June 30, 2018. The
trial was conducted in the federal state of Saarland in
Germany, a mixed urban and rural state with an area of
1004 sq. mi (2571 km2) and approximately 992,000 in-
habitants, in the context of a state-wide network of all
certified stroke centres (eight PSCs, two CSCs). All
emergency calls in this state are evaluated by a single
dispatch centre. Inclusion criteria were suspicion of
acute stroke by the EMS personnel on-scene, age of at
least 18 years, and willingness to participate. Exclusion
criteria were referral modes other than via EMS and crit-
ical illness requiring immediate transfer to the nearest
intensive care unit.
Triage SOP based on the LAMS instrument
The stroke triage SOP was a rule for all EMS stations in
the entire state. In this SOP, the following factors were
considered in triage decision-making: (1) LAMS score
(cut-off score of 4) [19]; (2) symptom onset times of 8 h
or less or presence of “wake-up” stroke; and (3) quality-
of-life aspects, such as severe comorbid conditions and
severe prestroke dependency [20].
The triage protocol was set in operation by the central
EMS coordinating authority of the state, the Zweckverband
für Rettungsdienst und Feuerwehralarmierung, Saar, on
May 30, 2015 (VAWMED-012) [20], and was accompanied
by state-wide structured training sessions held approxi-
mately every 3 months for EMS personnel in the field and
every 6 months for dispatch centre personnel in the context
of the 30 educational sessions per year required for EMS
personnel in the field. Moreover, the protocol was a com-
ponent of the educational curriculum of the state’s EMS
school.
Endpoints
The primary endpoint was accuracy of the triage SOP in
triaging stroke patients to the appropriate target hos-
pital, PSC versus CSC. Correct triage decision was de-
fined as a decision to transport patients with LVO to the
nearest CSC and to transport patients without LVO to
the nearest PSC (or to a CSC, if this was the nearest
stroke-treating hospital). LVO was defined as occlusion
of the intracranial internal carotid artery, the proximal
(M1) segments of the middle cerebral artery, or the basi-
lar artery.
Secondary endpoints were performance of the triage
protocol with regard to either LVO or intracranial
haemorrhage (ICH), the number of secondary interhos-
pital transfers, and the sensitivity and specificity of the
LAMS in detection of LVO itself. Documented stroke
management metrics included times from call to (1) "on
scene”, (2) hospital admission (“door”), (3) first neurolo-
gist contact, (4) start of non-contrast imaging, (5) start
of vascular imaging (in case of ischaemic stroke), (6)
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needle, (7) door of CSC after secondary transfer, and (8)
groin puncture. To determine short-term outcomes, we
assessed mRS scores at discharge and mortality rates.
Geocoding
For analysis of the potentially alternative conventional
pathway of the guideline-recommended transfer to the
nearest stroke-treating hospital, geocoding was per-
formed for each patient based on postal code, as previ-
ously described [21]. This approach allowed exact
identification of the level of care (PSC or CSC) offered
by the nearest stroke-treating hospital to which the indi-
vidual patient with stroke would normally have been
transferred.
Ethical aspects
The study protocol, the informed consent document,
and the subject information document were approved
by the Ethics Committee of the Medical Association
of the Saarland, Germany (AZ-257/17). Informed con-
sent was obtained from all patients or their legal rep-
resentatives and was documented in the receiving
hospitals. The otherwise separated datasets of the
EMS and of the hospital were pseudonymized and
linked only by the information from (1) the target
hospital, (2) the admission date, (3) the patient’s sex,
and (4) the patient’s year of birth.
Statistical analyses
Results are reported according to Strengthening The
Reporting of OBservational Studies in Epidemiology
(STROBE) guidelines [22]. Group comparisons were
analysed with the Mann-Whitney U Test or the Fisher
exact test. Statistical analyses were performed with
IBM SPSS Statistics for Windows, version 25.0.0.0
(IBM Corporation, Armonk, NY, USA).
Results
Demographic and medical characteristics
After the 4-month study period, the study was termi-
nated with a total of 1123 enrolled patients. Exclusion of
patients is specified in Fig. 1. Baseline demographic and
medical characteristics of the patients are presented in
Table 1. Of the 1123 patients, 644 (57.3%) had experi-
enced an acute ischaemic stroke, 84 patients (7.5%) had
experienced a haemorrhagic stroke, and 395 patients
(35.2%) had experienced stroke mimics. Of the 644 pa-
tients with ischaemic stroke, 129 (20.0%) underwent
thrombolysis; and 489 underwent vascular imaging,
which showed that 78 (12.1%) had LVO; 53 of these 78
patients (67.9%) were treated with MT.
Feasibility and performance of the LAMS-based
triage SOP in triage of stroke patients
This study demonstrated the feasibility of state-wide im-
plementation of a LAMS-based triage SOP with high ad-
herence. Only 60 of 1123 patients (5.3%) had no
Fig. 1 Strengthening The Reporting of Observational Studies in Epidemiology (STROBE) diagram illustrating the trial design and exclusion of
patients from the study. Patients with suspected stroke were enrolled in the hospital after evaluation for inclusion and exclusion criteria and after
informed consent had been obtained. For pseudonymization, separated data sets from the prehospital and in-hospital phases of acute stroke
management were linked exclusively on the basis of information about the date of stroke, target hospital, sex, and the patient’s year of birth
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documented LAMS score, and 941 of the 1123 patients
(83.8%) were triaged according to the LAMS score
(Table 1).
The triage SOP allowed triage to the appropriate hos-
pital with a sensitivity of 69.2% (95% confidence interval
(95%-CI): 59.0–79.5%) and a specificity of 84.9% (95%-
CI: 82.6–87.3%) (Table 2). In contrast, if the current
guidelines had been adhered to (transfer to the nearest
stroke-treating hospital), patients with LVO would have
been correctly triaged with a sensitivity of 17.9% (95%-
CI: 9.4–26.5%) and a specificity of 100% (95%-CI: 100–
100%).
Performance of the LAMS in identifying LVO
The LAMS itself, at a cut-off value of 4, exhibited a sen-
sitivity of 67.5% (95%-CI: 57.1–78.0%) and a specificity
of 83.5% (95%-CI: 81.0–86.0%) in detecting LVO
(Table 3). Moreover, this scale exhibited a sensitivity of
56.6% (95%-CI: 48.9–64.3%) and a specificity of 86.7%
(95%-CI: 84.3–89.1%) in detecting either LVO or ICH
(Table 3). The receiver operating characteristic (ROC)
curves obtained with a wider range of LAMS cut-off
scores are displayed in Fig. 2 and suggest that the cut-off
value of 4 is appropriate.
Similar results were obtained when the evaluation in-
cluded ICH as a condition for triage to a CSC (Table 3).
In accordance with this high triage accuracy, only 14 of
the 78 patients with LVO (17.9%) required secondary
transfer.
Stroke management metrics and short-term outcomes
Stroke management metrics are displayed in Table 4.
The median call-to-needle times for patients transferred
to a PSC were shorter than those for patients transferred
Table 1 Demographic and medical characteristics of the study population
Triage decision Transport destinationa
Total (n = 1123) CSC (n = 188) PSC (n = 935) CSC (n = 424) PSC (n = 699)
Demographic and prehospital data
Age, years; median (IQR) 78 (68–85) 74 (66–83) 79 (68–85) 76 (66–84) 80 (69–85)
Male sex, n (%) 565 (50.3) 97 (51.6) 468 (50.1) 218 (51.4) 347 (49.6)
Symptom onset to call, min; median (IQR) 55 (11–353) 19 (6–126) 68 (14–406) 36 (8–233) 74 (15–426)
LAMS, n/total n (%)
LAMS< 4 855/1123 (80.4) 49/855 (5.7) 806/855 (94.3) 269/855 (31.5) 586/855 (68.5)
LAMS≥4 208/1123 (19.6) 135/208 (64.9) 73/208 (35.1) 140/208 (67.3) 68/208 (32.7)
NIHSS admission, median (IQR)
All 4 (1–8) 10 (5–17) 3 (1–6) 5 (2–11) 3 (1–6)
Patients with strokes 4 (2–8) 8 (5–16) 3 (1–6) 5 (2–10) 3 (1–6)
Discharge diagnoses, n (%)
Ischaemic stroke 644 (57.3) 119 (63.3) 525 (56.1) 254 (59.9) 390 (55.8)
LVO stroke 78 (6.9) 54 (28.7) 24 (2.6) 58 (13.7) 20 (2.9)
Intracranial haemorrhage 84 (7.5) 28 (14.9) 45 (4.8) 56 (13.2) 39 (5.6)
Stroke mimics 395 (35.2) 41 (21.8) 354 (37.9) 125 (29.5) 270 (38.6)
Epileptic seizure 85 (7.6) 21 (11.2) 64 (6.8) 38 (9.0) 47 (6.7)
Migraine 11 (1.0) 1 (0.5) 11 (1.2) 3 (0.7) 8 (1.1)
Vestibulopathy 31 (2.8) 0 31 (3.3) 9 (2.1) 22 (3.1)
Infection 52 (4.6) 4 (2.1) 48 (5.1) 19 (4. 5) 33 (4.7)
Exsiccosis 17 (1.5) 0 17 (1.8) 4 (0.9) 13 (1.9)
Delirium 31 (2.8) 0 31 (3.3) 8 (1.9) 23 (3.3)
Hypertensive crisis 6 (0.5) 1 (0.5) 5 (0.5) 2 (0.5) 4 (0.6)
Peripheral facial palsy 11 (1.0) 0 11 (1.2) 6 (1.4) 5 (0.7)
Intoxication 6 (0.5) 1 (0.5) 5 (0.5) 2 (0.5) 4 (0.6)
Syncope 18 (1.6) 1 (0.5) 17 (1.8) 4 (0.9) 14 (2.0)
Other 86 (7.7) 12 (6.4) 74 (7.9) 31 (7.3) 55 (7.9)
CSC Comprehensive stroke centre, PSC Primary stroke centre, IQR Interquartile range, LAMS Los Angeles Motor Scale, NIHSS National Institutes of Health Stroke
Scale, mRS Modified Rankin Scale, LVO Large-vessel occlusion
a Including CSCs serving as PSCs if they are the closest stroke centre at all
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to a CSC, and, conversely, call-to-groin puncture times
were longer for patients transferred to a PSC than for
those transferred to a CSC (Table 4).
In agreement with their lower LAMS scores, patients
admitted to PSCs had better discharge modified Rankin
scale (mRS) scores (1; interquartile range (IQR), 0–3)
than did those admitted to a CSC (mRS score, 2; IQR,
1–5; p < 0.001). In addition, mortality rates were lower
for patients transferred to a PSC (22, 4.8%) than for
those transferred to a CSC (41, 11.9%; p < 0.05). Simi-
larly, among patients with a stroke diagnosis, those ad-
mitted to PSCs had better discharge mRS scores (1; IQR,
0–3) than did those admitted to a CSC (mRS score, 2;
IQR, 1–5; p < 0.001); they also exhibited lower mortality
rates (12 patients, 3.6%) than did those admitted to a
CSC (22 patients, 8.4%; p < 0.05).
Discussion
The current guideline-recommended practice of transfer-
ring each patient to the nearest stroke-treating hospital,
usually a hospital not offering thrombectomy, may delay
or even preclude thrombectomy for patients with LVO.
The results show that state-wide implementation of an
SOP requesting the use of LAMS for triage decisions is
feasible with high adherence and that this intervention
can improve triage decision-making in regard to the ap-
propriate target hospital in clinical practice.
Our evaluation of the effects of the state-wide implemen-
tation of an EMS SOP based on the LAMS achieved a sen-
sitivity of 69.2% and a specificity of 84.9% in transferring
patients with LVO to the appropriate target hospital. In ac-
cordance with such a high accuracy of triage decisions, we
observed a low rate of secondary transfers (only 17.9% of
LVO patients). In contrast, the conventional, guideline-
recommended approach of transferring every patient to the
nearest stroke-treating hospital, as determined by geocod-
ing for each of the patients, would have achieved a sensitiv-
ity of only 17.9% and a specificity of 100%, a finding
supporting the benefit of using the LAMS-based SOP. (The
high specificity achieved by the modelled conventional
pathway can be explained by the fact that “non-LVO” pa-
tients would always arrive at the “correct” hospital: the
Table 3 Performance of the LAMS tool (cut-off value, ≥4) in identification of LVO and LVO or ICH
All patientsa (n = 920) Patients with strokeb (n = 547)
Variable, n/total n (%) LVO LVO or ICH LVO LVO or ICH
Sensitivity 52/77 (67.5; 57.1–78.0) 90/159 (56.6; 48.9–64.3) 52/77 (67.5; 57.1–78.0) 90/158 (57.0; 49.2–64.7)
Specificity 704/843 (83.5; 81.0–86.0) 660/761 (86.7; 84.3–89.1) 366/470 (77.9; 74.1–81.6) 323/389 (83.0; 79.3–86.8)
Positive predictive value 52/191 (27.2; 20.9–33.5) 90/191 (47.1; 40.0–54.2) 52/156 (33.3; 25.9–40.7) 90/156 (57.7; 49.9–65.4)
Negative predictive value 704/729 (96.6; 95.3–97.9) 660/729 (90.5; 88.4–92.7) 366/391 (93.6; 91.2–96.0) 323/391 (82.6; 78.9–86.4)
LAMS Los Angeles Motor Scale, LVO Large-vessel occlusion, ICH Intracranial haemorrhage; Independently of having received vascular imaging, patients with ICH or
stroke mimics are classified as LVO-negative
a 60 of 1123 (5.3%) patients had no documented LAMS score, and 155 of 644 (24.1%) ischaemic stroke patients did not undergo vascular imaging; b 38 of 728
(5.2%) patients had no documented LAMS score, and 155 of 644 (24.1%) ischaemic stroke patients did not undergo vascular imaging
95% confidence intervals are reported in brackets
Table 2 Performance of the triage SOP and modelled conventional care assessed via geocoding in patients with LVO and with LVO
or ICHa
Triage SOP (n = 968) Modelled conventional careb (n = 968)
LVO, n/total n (%)
Sensitivity 54/78 (69.2; 59.0–79.5) 14/78 (17.9; 9.4–26.5)
Specificity 756/890 (84.9; 82.6–87.3) 890/890 (100; 100–100)
Positive Predictive Value 54/188 (28.7; 22.3–35.2) 14/14 (100; 100–100)
Negative Predictive Value 756/780 (96.9; 95.7–98.1) 890/954 (93.3; 91.7–94.9)
LVO or ICH, n/total n (%)
Sensitivity 82/162 (50.6; 42.9–58.3) 38/162 (23.5; 16.9–30.0)
Specificity 700/806 (86.8; 84.5–89.2) 806/806 (100; 100–100)
Positive Predictive Value 82/188 (43.6; 36.5–50.7) 38/38 (100; 100–100)
Negative Predictive Value 700/780 (89.7; 87.6–91.9) 806/930 (86.7; 84.5–88.9)
SOP Standard operating procedure, LVO Large-vessel occlusion, ICH Intracranial haemorrhage
a 60 of 1123 (5.3%) patients had no documented LAMS score, and 155 of 644 (24.1%) ischaemic stroke patients did not undergo vascular imaging; b Conventional
care was the guideline-recommended transfer to the nearest stroke centre, as calculated via geocoding in each patient. CSCs served as PSCs if they were the
nearest stroke centre
95% confidence intervals are reported in brackets
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nearest one, regardless of the MT options available there.)
Thus, this finding strongly suggests that implementation of
a protocol using the LAMS for triage decision-making is
superior to the conventional approach of transporting every
patient to the nearest hospital.
Similar values were obtained when ICH was included
as a “target condition” for triage to a CSC. Although in-
creasing evidence indicates that the “time-is-brain” con-
cept is also valid for patients with haemorrhagic stroke
and that these patients could also benefit from rapid
Fig. 2 Receiver operating characteristic curves of the Los Angeles Motor Scale at various cut-off scores for diagnosing large-vessel occlusion (LVO)
selectively (dashed line) with an area under the curve of 0.798, or for diagnosing LVO or intracerebral haemorrhage (solid line) with an area under
the curve of 0.751. Diagonal segments are produced by ties. The dotted line depicts randomness
Table 4 Stroke management metrics
Total (n = 1077) CSC (n = 400) PSC (n = 677) p-value
Stroke-management metrics, min; median (IQR)
Time from call to
On-scene 10 (8–13) 9 (7–12) 10 (8–13) 0.105
Doora 49 (41–59) 51 (41–61) 48 (40–59) 0.008
First contact to neurologist 51 (42–62) 51 (42–62) 52 (43–62) 0.739
Non-contrast imaging 75 (60–99) 73 (58–104) 76 (62–96) 0.698
Initial vascular imaging 75 (62–99) 74 (60–99) 76 (64–98) 0.005
Needle 87 (67–100) 93 (73–103) 79 (66–95) 0.017
Groin puncture 112 (95–135) 105 (88–121) 292 (230–515) < 0.001
Time from door to
Non-contrast imaging 23 (13–42) 18 (11–43) 26 (16–40) < 0.001
Initial vascular imaging 21 (15–38) 19 (14–33) 27 (20–42) < 0.001
Needle 35 (27–49) 40 (29–50) 32 (26–48) 0.054
Groin puncture 57 (48–85) 53 (47–74) 233 (172–446) < 0.001
CSC Comprehensive stroke centre, PSC Primary stroke centre, IQR Interquartile range
a Time to admission at the first receiving hospital
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specialist treatment at a CSC [12, 23], evidence from
randomized studies regarding primary transfer to CSCs
is still scarce [24].
Regarding the LAMS itself, this instrument detected
LVO with a sensitivity of 67.5% and a specificity of
83.5% and detected either LVO or ICH with a sensi-
tivity of 56.6% and a specificity of 86.7%. Calculating
the accuracy of a variety of alternative LAMS cut-off
scores confirmed that the cut-off score of 4 is appro-
priate. Thus, these are within the range of results of
most earlier validation studies on the LAMS. E.g., a
subgroup of 94 patients from the FAST-MAG trial
who underwent vascular imaging found that the LAMS
detected LVO with a sensitivity of 76% and a specificity of
65% [12], and two European studies reporting sensitivities
of 63 and 38%, and specificities of 84 and 93%, respectively
[17, 18].
However, these earlier studies did not use their
LAMS results for triaging patients in clinical practice.
At the same time, the results also corroborate the
conclusions of previous meta-analyses indicating that
all of the LVO scales tested still miss a substantial
proportion of LVOs [25, 26].
While the strengths of this study are the pseudony-
mized linkage of separated prehospital and in-hospital
data sets, and the high degree of data completeness, one
limitation of the study is the lack of a control group.
The alternative of retrieving historical data before imple-
menting the SOP may, however, have caused a bias by
secular effects, and randomization was not possible in
this state-wide EMS rule. However, geocoding allowed
us to exactly identify the level of care offered by the near-
est stroke-treating hospital in each patient if the conven-
tional practice had been applied. Furthermore, in this
real-life-study, vascular imaging has not been performed
in all patients admitted to the ten hospitals, thus result-
ing in omission of 24% of stroke patients from evalu-
ation. In the future, triage accuracy may be further
enhanced by improved scales, by the inclusion of add-
itional factors such as screening tools for treatment eligi-
bility or for mimicking conditions [27], or by additional
telemedical consultation with the CSC team [16].
Conclusion
The prehospital identification of stroke patients with
LVO that should be directly transported to a thrombec-
tomy capable centre is an unsolved medical problem.
Here, we show for the, to our knowledge, first time that
a state-wide EMS SOP for stroke management request-
ing determination of the LAMS score is feasible with
high adherence and can indeed be beneficial in triage
decision-making regarding the most appropriate target
hospital.
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